SK13312001A3 - Spôsob prípravy stabilnej nehygroskopickej soli L(-)-karnitínu, granulát alebo prášok s obsahom kyslého fumarátu L(-)-karnitínu - Google Patents

Spôsob prípravy stabilnej nehygroskopickej soli L(-)-karnitínu, granulát alebo prášok s obsahom kyslého fumarátu L(-)-karnitínu Download PDF

Info

Publication number
SK13312001A3
SK13312001A3 SK1331-2001A SK13312001A SK13312001A3 SK 13312001 A3 SK13312001 A3 SK 13312001A3 SK 13312001 A SK13312001 A SK 13312001A SK 13312001 A3 SK13312001 A3 SK 13312001A3
Authority
SK
Slovakia
Prior art keywords
carnitine
granulate
powder
mass
weight
Prior art date
Application number
SK1331-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S. P. A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S. P. A.
Publication of SK13312001A3 publication Critical patent/SK13312001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
SK1331-2001A 1999-03-19 2000-03-16 Spôsob prípravy stabilnej nehygroskopickej soli L(-)-karnitínu, granulát alebo prášok s obsahom kyslého fumarátu L(-)-karnitínu SK13312001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000551A IT1312018B1 (it) 1999-03-19 1999-03-19 Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina.
PCT/EP2000/002344 WO2000056701A1 (en) 1999-03-19 2000-03-16 An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine

Publications (1)

Publication Number Publication Date
SK13312001A3 true SK13312001A3 (sk) 2002-05-09

Family

ID=11382333

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1331-2001A SK13312001A3 (sk) 1999-03-19 2000-03-16 Spôsob prípravy stabilnej nehygroskopickej soli L(-)-karnitínu, granulát alebo prášok s obsahom kyslého fumarátu L(-)-karnitínu

Country Status (22)

Country Link
US (1) US6372940B1 (pt)
EP (1) EP1163207B1 (pt)
JP (1) JP2002540094A (pt)
KR (1) KR100664560B1 (pt)
CN (1) CN1147462C (pt)
AR (1) AR023101A1 (pt)
AT (1) ATE247627T1 (pt)
AU (1) AU4105800A (pt)
CA (1) CA2359106A1 (pt)
CZ (1) CZ299312B6 (pt)
DE (1) DE60004649T2 (pt)
DK (1) DK1163207T3 (pt)
ES (1) ES2204555T3 (pt)
HK (1) HK1042468A1 (pt)
HU (1) HUP0200402A3 (pt)
IT (1) IT1312018B1 (pt)
NZ (1) NZ512640A (pt)
PL (1) PL199614B1 (pt)
PT (1) PT1163207E (pt)
SI (1) SI1163207T1 (pt)
SK (1) SK13312001A3 (pt)
WO (1) WO2000056701A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631569B1 (fr) * 1988-05-20 1990-07-27 Renault Automation Detecteur de proximite magnetique destine notamment a la decoupe laser
ITRM20010030A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per la loro pr
PT1368349E (pt) * 2001-02-24 2007-04-30 Boehringer Ingelheim Pharma Derivados de xantina, sua preparação e sua utilização como medicamento
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CN101209975B (zh) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
US20110112069A1 (en) * 2007-08-17 2011-05-12 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010018217A2 (en) * 2008-08-15 2010-02-18 Boehringer Ingelheim International Gmbh Organic compounds for wound healing
US8513264B2 (en) 2008-09-10 2013-08-20 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP3646859A1 (en) 2009-11-27 2020-05-06 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
AU2011249722B2 (en) 2010-05-05 2015-09-17 Boehringer Ingelheim International Gmbh Combination therapy
BR112012032579B1 (pt) 2010-06-24 2021-05-11 Boehringer Ingelheim International Gmbh uso de linagliptina e composição farmacêutica compreendendo linagliptina e insulina basal de longa duração
EP2425834A1 (en) * 2010-09-06 2012-03-07 Lonza Ltd. Process for the production of l-carnitine tartrate
JP2012092036A (ja) * 2010-10-26 2012-05-17 Mitsubishi Rayon Co Ltd カルニチンの塩の製造方法
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
HUE043540T2 (hu) 2011-07-15 2019-08-28 Boehringer Ingelheim Int Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US20140316156A1 (en) * 2013-04-18 2014-10-23 Deborah Warner Method of producing therapeutic agent
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina
CN106748845B (zh) * 2016-12-23 2018-11-20 东北制药集团股份有限公司 一种左旋肉碱盐微粉的制备方法
KR20190017310A (ko) 2017-08-10 2019-02-20 주식회사 셀트리온화학연구소 약제학적 성질이 개선된 l-카르니틴 화합물의 염, 이의 제조방법, 이를 함유하는 약학 조성물
JP6964876B2 (ja) * 2017-11-27 2021-11-10 株式会社古川リサーチオフィス オロット酸−カルニチン混合体粉体又はフマル酸−カルニチン混合体粉体の製造方法
CN108383741A (zh) * 2018-03-16 2018-08-10 开原亨泰化工有限公司 一种制备左旋肉碱成盐的新方法
CN109096129B (zh) * 2018-09-30 2021-04-27 东北制药集团股份有限公司 一种左旋肉碱酒石酸盐的制备方法
CN109535022B (zh) * 2018-11-12 2022-03-01 天津大学 一种提高左旋肉碱富马酸盐流动性的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
PT914315E (pt) * 1996-05-31 2001-07-31 Sigma Tau Ind Farmaceuti Sais nao higroscopicos estaveis de l(-)carnitina e alcanoil l(-)carnitinas processo para a sua preparacao e composicoes solidas administraveis oralmente contendo tais sais
IT1289974B1 (it) * 1997-02-25 1998-10-19 Aldo Fassi Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine

Also Published As

Publication number Publication date
PT1163207E (pt) 2003-12-31
JP2002540094A (ja) 2002-11-26
DE60004649T2 (de) 2004-03-18
HUP0200402A2 (hu) 2002-05-29
PL199614B1 (pl) 2008-10-31
PL349894A1 (en) 2002-09-23
EP1163207A1 (en) 2001-12-19
HK1042468A1 (zh) 2002-08-16
ATE247627T1 (de) 2003-09-15
WO2000056701A1 (en) 2000-09-28
HUP0200402A3 (en) 2002-11-28
DK1163207T3 (da) 2003-12-01
CN1339023A (zh) 2002-03-06
CZ20013376A3 (cs) 2002-02-13
CN1147462C (zh) 2004-04-28
ES2204555T3 (es) 2004-05-01
CZ299312B6 (cs) 2008-06-18
IT1312018B1 (it) 2002-04-04
CA2359106A1 (en) 2000-09-28
NZ512640A (en) 2003-03-28
US6372940B1 (en) 2002-04-16
ITMI990551A1 (it) 2000-09-19
AR023101A1 (es) 2002-09-04
AU4105800A (en) 2000-10-09
KR20010102288A (ko) 2001-11-15
SI1163207T1 (en) 2003-12-31
DE60004649D1 (de) 2003-09-25
KR100664560B1 (ko) 2007-01-03
EP1163207B1 (en) 2003-08-20

Similar Documents

Publication Publication Date Title
SK13312001A3 (sk) Spôsob prípravy stabilnej nehygroskopickej soli L(-)-karnitínu, granulát alebo prášok s obsahom kyslého fumarátu L(-)-karnitínu
AU2002355624B2 (en) Crystalline composition containing escitalopram
RU2106140C1 (ru) Фармацевтическая композиция, способ ее получения, физическая форма n-[4-[5-(циклопентилоксикарбонил)амино-1-метилиндол-3-ил-метил]-3-метоксибензоил]-2-метилбензолсульфонамида, способы ее получения
AU750978B2 (en) Polymorphic crystalline forms of celecoxib
CN107176923A (zh) 拉奎尼莫钠晶体及其制备方法
FI112030B (fi) Menetelmä S(+)-ibuprofeeni-partikkeleiden valmistamiseksi
KR20030024833A (ko) 시탈로프람을 함유하는 약학 조성물
CN104829622A (zh) 一种枸橼酸西地那非化合物及其药物组合物
CN114288259B (zh) 一种维生素b2的速释制剂及制备方法
HRP20030950A2 (en) Granular preparations of gaboxadol
CA2626242A1 (en) Polymorph transformation of zolpidem in tablet matrix
JP2004010575A (ja) 溶解性を改善した医薬組成物
CA2105913A1 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
RU2183119C1 (ru) Фармацевтическая композиция, обладающая спазмолитической активностью, способ ее получения
CA2413578C (en) Use of dicalcium phosphate anhydride powder
AU2002236157B2 (en) Pharmaceutical formulation comprising atorvastatin calcium
AU2002236157A1 (en) Pharmaceutical formulation comprising atorvastatin calcium